1st Quarter - Termination Amendment

FABIANI & COMPANY for CLINICAL DATA INC

Firm
Client
Income
—
Expenses
—
Terminated
Feb 28, 2011

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2011 — Replaced
1st Quarter - Termination Amendment (this page) Jul 20, 2011 — Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

The Genomics and Personalized Medicine Act of 2007; Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations; TRICARE reimbursement

LobbyistCovered position, as disclosed
LINDSAY BOMAR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Defense, Dept of (DOD)

Science/Technology SCI

Inform DoD program managers of Clinical Data's programs.

LobbyistCovered position, as disclosed
MELISSA DUPREE —

Contacted: HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE

Health Issues HCR

The Genomics and Personalized Medicine Act; Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations; TRICARE reimbursement

LobbyistCovered position, as disclosed
LINDSAY BOMAR —

Contacted: HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.